4.5 Article

Comparison of the relative activities of inducing platelet apoptosis stimulated by various platelet-activating agents

Journal

PLATELETS
Volume 20, Issue 8, Pages 575-581

Publisher

TAYLOR & FRANCIS INC
DOI: 10.3109/09537100903315704

Keywords

Apoptosis; caspases; phosphatidylserine exposure; platelet; mitochondrial depolarization

Funding

  1. National Science Council, Taiwan [NSC97-2320-B-038-016-MY3]
  2. Wan-Fan Hospital-Taipei Medical University [96-TMU-WFH-01]

Ask authors/readers for more resources

Apoptosis-like events are known to occur in anuclear platelets. Although the mechanisms responsible for these events are still not completely understood, studies suggested that some platelet agonists can activate platelet apoptosis. However, the relative activities of various platelet agonists in inducing apoptosis have not yet been investigated. In the present study we explored this issue, and attempted to identify the correlation between platelet activation and apoptosis. In a platelet aggregation study, there were no significant differences respectively stimulated by arachidonic acid (AA; 100 mu M), ADP (20 mu M), collagen (10 mu g/mL), thrombin (0.1 U/mL), U46619 (10 mu M), and A23187 (5 mu M). In a subsequent study, we fixed these concentrations of agonists to further compare their relative activities in inducing platelet apoptosis. Our results found that thrombin, U46619, and A23187 possess stronger activities than the other agonists in inducing platelet apoptosis (i.e., phosphatidylserine exposure, mitochondrial membrane potential depolarization, eukaryotic initiation factor (eIF)2 alpha, and caspase activation). On the other hand, AA induced no apoptotic events in platelets. Based on this approach, we demonstrated for the first time that thrombin, U46619, and A23187, but not AA, possess stronger activity in inducing platelet apoptosis. In addition, we also found that platelet activation might not necessarily be associated with the occurrence of platelet apoptosis. The in vivo physiological function of the apoptotic machinery in platelets is not yet clearly understood, and needs to be further investigated in the future.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell Biology

Norcantharidin, a clinical used chemotherapeutic agent, acts as a powerful inhibitor by interfering with fibrinogen-integrin αIIbβ3 binding in human platelets

Chih-Hsuan Hsia, Wan-Jung Lu, Kuan-Hung Lin, Duen-Suey Chou, Pitchairaj Geraldine, Thanasekaran Jayakuma, Nen-Chung Chang, Joen-Rong Sheu

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)

Article Biochemistry & Molecular Biology

Licochalcone A attenuates glioma cell growth in vitro and in vivo through cell cycle arrest

Wan Jung Lu, Gong Jhe Wu, Ray Jade Chen, Chao Chien Chang, Li Ming Lien, Ching Chuan Chiu, Mei Fang Tseng, Li Ting Huang, Kuan Hung Lin

FOOD & FUNCTION (2018)

Article Cell Biology

New therapeutic strategy of hinokitiol in haemorrhagic shock-induced liver injury

Wan-Jung Lu, Kuan-Hung Lin, Mei-Fang Tseng, Kuo-Ching Yuan, Hung-Chang Huang, Joen-Rong Sheu, Ray-Jade Chen

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)

Article Medicine, General & Internal

Embelin as a Novel Inhibitor of PKC in the Prevention of Platelet Activation and Thrombus Formation

Jiun Yi Li, Ray Jade Chen, Li Ting Huang, Tzu Yin Lee, Wan Jung Lu, Kuan Hung Lin

JOURNAL OF CLINICAL MEDICINE (2019)

Article Multidisciplinary Sciences

VAS2870 and VAS3947 attenuate platelet activation and thrombus formation via a NOX-independent pathway downstream of PKC

Wan Jung Lu, Jiun Yi Li, Ray Jade Chen, Li Ting Huang, Tzu Yin Lee, Kuan Hung Lin

SCIENTIFIC REPORTS (2019)

Article Biochemistry & Molecular Biology

Phospholipase D1 and D2 Synergistically Regulate Thrombus Formation

Li-Ming Lien, Wan-Jung Lu, Ting-Yu Chen, Tzu-Yin Lee, Hsueh-Hsiao Wang, Hsien-Yu Peng, Ray-Jade Chen, Kuan-Hung Lin

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Chemistry, Multidisciplinary

Magnolol, A Novel Antagonist of Thrombin and PAR-1, Inhibits Thrombin-Induced Connective Tissue Growth Factor (CTGF) Expression in Vascular Smooth Muscle Cells and Ameliorate Pathogenesis of Restenosis in Rats

Wen-Chin Ko, Chia-Ti Tsai, Kai-Cheng Hsu, Yu-Che Cheng, Tony Eight Lin, Yi-Ling Chen, Chuang-Ye Hong, Wan-Jung Lu, Chun-Ming Shih, Ting-Lin Yen

APPLIED SCIENCES-BASEL (2020)

Article Biochemistry & Molecular Biology

Influence of Vincristine, Clinically Used in Cancer Therapy and Immune Thrombocytopenia, on the Function of Human Platelets

Li-Ming Lien, Wan-Jung Lu, Kuan-Hung Lin, Ling-Hsuan Kang, Ting-Yu Chen, Bo-Jung Lin, Yung-Chang Lu, Chun-Yao Huang, Chun-Ming Shih, Hsuan Chen, Yao-Chou Tsai, Ray-Jade Chen, Joen-Rong Sheu

Summary: Vincristine exerts its antiplatelet effects by suppressing GPVI signaling, reducing platelet aggregation and granule release, with a higher inhibitory effect on collagen-mediated platelet aggregation, without affecting normal hemostasis.

MOLECULES (2021)

Article Neurosciences

MicroRNA-489-3p attenuates neuropathic allodynia by regulating oncoprotein DEK/TET1-dependent epigenetic modification in the dorsal horn

Cheng-Yuan Lai, Ming-Chun Hsieh, Chou-Ming Yeh, Po-Sheng Yang, Jen-Kun Cheng, Hsueh-Hsiao Wang, Kuan-Hung Lin, Siao-Tong Nie, Tzer-Bin Lin, Hsien-Yu Peng

Summary: The study revealed that DEK, regulated by miR-489-3p, is induced in spinal dorsal horn neurons after spinal nerve ligation (SNL). DEK recruits TET1 to promote the transcription of specific genes in the dorsal horn, contributing to neuropathic allodynia. Inhibiting miR-489-3p expression attenuated allodynia behavior, suggesting a potential target for treating neuropathic allodynia.

NEUROPHARMACOLOGY (2022)

Article Biochemistry & Molecular Biology

Melatonin Relieves Paclitaxel-Induced Neuropathic Pain by Regulating pNEK2-Dependent Epigenetic Pathways in DRG Neurons

Ming-Chun Hsieh, Cheng-Yuan Lai, Li-Ting Lin, Dylan Chou, Chou-Ming Yeh, Jen-Kun Cheng, Hsueh-Hsiao Wang, Kuan-Hung Lin, Tzer-Bin Lin, Hsien-Yu Peng

Summary: The neurohormone melatonin shows promising potential in alleviating neuropathic pain caused by chemotherapy, with its analgesic effects mediated through melatonin receptor 2. Multiple administrations of melatonin during chemotherapy may be more effective in relieving allodynia/hyperalgesia and inhibiting the epigenetic program in neurons compared to a single administration after chemotherapy.

ACS CHEMICAL NEUROSCIENCE (2023)

No Data Available